[1]黄利民,徐源佑,王璐璐,等.IL-6/STAT3信号通路在脓毒症所致骨骼肌消耗中的作用机制研究[J].肠外与肠内营养杂志,2023,(06):368-374.[doi:DOI : 10.16151/j.1007-810x.2023.06.009]
 HUANG Li-min,XU Yuan-you,WANG Lu-lu,et al.Mechanism of IL-6/STAT3 signaling pathway in sepsis induced skeletal muscle wasting[J].PARENTERAL & ENTERAL NUTRITION,2023,(06):368-374.[doi:DOI : 10.16151/j.1007-810x.2023.06.009]
点击复制

IL-6/STAT3信号通路在脓毒症所致骨骼肌消耗中的作用机制研究()
分享到:

《肠外与肠内营养》杂志[ISSN:1007-810X/CN:32-1477/R]

卷:
期数:
2023年06期
页码:
368-374
栏目:
论著
出版日期:
2023-12-10

文章信息/Info

Title:
Mechanism of IL-6/STAT3 signaling pathway in sepsis induced skeletal muscle wasting
作者:
黄利民1徐源佑 2王璐璐2陈鑫玥 2段 婷 2陆国玉 12
1.蚌埠医学院第一附属医院急诊外科,安徽蚌埠 233000;2.南京大学医学院附属金陵医院/东部战区总医院急诊医学科,江苏南京 210002
Author(s):
HUANG Li-min1 XU Yuan-you2 WANG Lu-lu2 CHEN Xin-yue2 DUAN Ting2 LU Guo-yu12
1.Department of Emergency Surgery, the First Affiliated Hospital of Bengbu Medical College, Bengbu233000, Anhui, China;2. Department of Emergency Medicine, Jinling Hospital, Medical School ofNanjing University, Nanjing 210002, Jiangsu, China
关键词:
脓毒症 骨骼肌消耗 白介素-6 炎症因子
Keywords:
Sepsis Skeletal muscle wasting Interleukin-6 Inflammatory cytokine
分类号:
R459.7
DOI:
DOI : 10.16151/j.1007-810x.2023.06.009
文献标志码:
A
摘要:
目的:探索 IL-6/STAT3信号通路在腹腔脓毒症所导致的骨骼肌消耗中的具体作用及机制。 方法:10周龄 SPF级 C57BL/6健康雄性小鼠随机分为对照组(假手术组)和盲肠结扎穿孔制备腹腔脓毒症组后,在脓毒症组内随机分为对照脓毒症组、脓毒症+抗 IL-6单抗组以及脓毒症+酪氨酸激酶抑制剂 AG490组,以观察阻断 IL-6信号通路对脓毒症小鼠骨骼肌消耗的影响。实验周期为 72 h,抗 IL-6单抗组及 AG490的给药方式均为腹腔注射,每24小时给药一次。实验结束后留取小鼠的双侧后肢背侧腓肠肌,称重后制作骨骼肌冰冻切片。免疫荧光染色检测小鼠骨骼肌层粘连蛋白(Laminin蛋白),并检测小鼠骨骼肌纤维横截面积。q-PCR以及 Western Blot 方法检测小鼠骨骼肌萎缩和炎症相关蛋白表达。 结果:与对照组(假手术组)相比,脓毒症小鼠的 IL-6信号通路显著激活,表现为建模后 24 h、48 h 以及 72 h 的 IL-6 水平及 p-STAT3/STAT3 比值显著升高(P < 0.05),而骨骼肌肌球蛋白重链(MYHC)含量显著下降(P < 0.05)。通过腹腔注射抗 IL-6单抗组或者 AG490阻断 IL-6/STAT3信号通路,可显著的增加小鼠的体质量及腓肠肌重量(P < 0.05),且增加小鼠的骨骼肌平均肌纤维面积及骨骼肌平均纤维直径(P <0.01),并显著的降低骨骼肌组织中萎缩相关基因 Murf-1(P < 0.05)和 Atrogin-1(P < 0.05)的表达。同时,小鼠的骨骼肌 MYHC蛋白表达量均显著增加(P < 0.01)。 结论:脓毒症状态下,IL-6升高导致的 IL-6/STAT3 信号通路激活是导致骨骼肌组织萎缩的重要原因之一。通过增加 IL-6的清除,或者阻断 IL-6的细胞内信号传导途径,可有效的改善脓毒症小鼠的骨骼肌消耗情况。
Abstract:
Objective: To explore the specific role and mechanism of IL-6/STAT3 signaling pathway in skeletalmuscle wasting caused by abdominal sepsis. Method: SPF C57BL/6 healthy 10-week-old male mice were randomlydivided into control group (sham operation group) and abdominal sepsis group (by cecum ligation and puncture). Afterthat, sepsis group was randomly divided into control sepsis group, sepsis + anti-IL-6 monoclonal antibody group andsepsis + tyrosine kinase inhibitor AG490 group. The experimental period was 72 hours. The anti-IL-6 monoclonalantibody group and AG490 were administered by intraperitoneal injection every 24 hours. The mice were euthanized andboth gastrocnemius muscles were removed 24 hours after the last injection. The laminin distribution in the muscles wasassessed following immunofluorescence staining, and the cross-sectional area were assessed. q-PCR and Western Blot was used to measure the expression of proteins related to atrophy and inflammation in skeletal muscle. Results:Compared with the control group (sham operation group), the IL-6 signaling pathway was significantly activated insepsis mice, as IL-6 levels and p-STAT3/STAT3 ratio were significantly increased at 24, 48, and 72 hours after CLPperforming (P < 0.05), while MYHC content was significantly decreased (P < 0.05). IL-6/STAT3 signaling pathwayblocking by injection of anti-IL-6 monoclonal antibody or AG490 could significantly increase body weight andgastrocnemius muscle weight (P < 0.05), and also increase the mean muscle fiber areas and mean muscle fiber diameterscompared with those in the sepsis group (P < 0.01). In addition, the atrophy-related gene expression of Murf-1 andAtrogin-1 in the IL-6 blocking group was significantly lower than that in the sepsis group (P < 0.05), while the proteinexpression of MYHC in skeletal muscle was significantly increased (P < 0.01). Conclusion: In sepsis, activation of IL-6/STAT3 signaling pathway caused by IL-6 elevation plays a pivotal role in skeletal muscle atrophy. Increasing theclearance or blocking the intracellular signaling pathway of IL-6 could effectively alleviate the skeletal muscle atrophyfor sepsis mice.

参考文献/References:


[1] Vanhorebeek I, Latronico N, Van den Berghe G. ICU-acquiredweakness. Intensive Care Med, 2020, 46(4):637-653.
[2] Kanova M, Kohout P. Molecular Mechanisms UnderlyingIntensive Care Unit-Acquired Weakness and Sarcopenia. Int JMol Sci, 2022, 23(15):8396.
[3] Bierbrauer J, Koch S, Olbricht C, et al. Early type II fiber atrophyin intensive care unit patients with nonexcitable musclemembrane. Crit Care Med, 2012, 40(2):647-650.
[4] Madaro L, Passafaro M, Sala D, et al. Denervation-activatedSTAT3-IL-6 signalling in fibro-adipogenic progenitors promotesmyofibres atrophy and fibrosis. Nat Cell Biol, 2018, 20(8):917-927.
[5] Pototschnig I, Feiler U, Diwoky C, et al. Interleukin-6 initiatesmuscle- and adipose tissue wasting in a novel C57BL/6 model ofcancer-associated cachexia. J Cachexia Sarcopenia Muscle, 2023,14(1):93-107.
[6] Zanders L, Kny M, Hahn A, et al. Sepsis induces interleukin 6,gp130/JAK2/STAT3, and muscle wasting. J Cachexia SarcopeniaMuscle, 2022, 13(1):713-727.
[7] Wen Z, Zhong Z, Darnell JE. Maximal activation of transcriptionby Stat1 and Stat3 requires both tyrosine and serinephosphorylation. Cell, 1995, 82(2):241-250.
[8] Schmidt F, Kny M, Zhu X, et al. The E3 ubiquitin ligase TRIM62and inflammation-induced skeletal muscle atrophy. Crit Care,2014, 18(5):545.
[9] Jiang S, Shi D, Bai L, Niu T, Kang R, Liu Y. Inhibition ofinterleukin-6 trans-signaling improves survival and preventscognitive impairment in a mouse model of sepsis. IntImmunopharmacol, 2023, 119:110169.
[10] Puthucheary ZA, Rawal J, McPhail M, et al. Acute SkeletalMuscle Wasting in Critical Illness. JAMA, 2013, 310(15): 1591-1600.
[11] 张树泽,吴国豪 .骨骼肌消耗和蛋白质代谢的研究现状 .肠外与肠内营养, 2018, 25(6):374-377.
[12] 吴国豪 . 重视外科病人骨骼肌丢失的防治 . 中华消化外科杂志,2021,20(11):1158-1161.
[13] Testa MTJ, Cella PS, Marinello PC, et al. Resistance TrainingAttenuates Activation of STAT3 and Muscle Atrophy in TumorBearing Mice. Front Oncol, 2022, 12:880787.
[14] Pelosi M, De Rossi M, Barberi L, et al. IL-6 Impairs MyogenicDifferentiation by Downmodulation of p90RSK/eEF2 and mTOR/p70S6K Axes, without Affecting AKT Activity. BIOMED RESINT, 2014, 2014: 206026.
[15] Guadagnin E, Mázala D, Chen Y. STAT3 in Skeletal MuscleFunction and Disorders. INT J MOL SCI, 2018, 19(8):2265.
[16] 朱 曦, 李 杨, 徐兴伟, 等 .胃癌根治术后肌肉减少症患病率及肠内营养支持的作用 . 肠外与肠内营养, 2019, 26(3):134-138.
[17] Xie T, Lv T, Zhang T, et al. Interleukin-6 promotes skeletalmuscle catabolism by activating tryptophan-indoleamine 2, 3-dioxygenase 1-kynurenine pathway during intra-abdominalsepsis. J Cachexia Sarcopenia Muscle, 2023;14(2):1046-1059.
[18] Yoshihara I, Kondo Y, Okamoto K, Tanaka H. Sepsis-AssociatedMuscle Wasting: A Comprehensive Review from Bench toBedside. Int J Mol Sci, 2023, 24(5):5040.
[19] Frost RA, Nystrom GJ, Jefferson LS, et al. Hormone, cytokine,and nutritional regulation of sepsis-induced increases in atrogin-1and MuRF1 in skeletal muscle. Am J Physiol Endocrinol Metab,2007, 292(2):E501-E512.
[20] Latchman HK, Wette SG, Ellul DJ, et al. Fiber Type Identification of Human Skeletal Muscle. J Vis Exp, 2023, (199).

相似文献/References:

[1]张树泽 综述,吴国豪 审校.骨骼肌消耗和蛋白质代谢的研究现状[J].肠外与肠内营养杂志,2018,(06):374.[doi:10.16151/j.1007-810x.2018.11.012]
 ZHANG Shu-ze reviewing,WU Guo-hao checking.Research status of skeletal muscle consumption and protein Metabolism[J].PARENTERAL & ENTERAL NUTRITION,2018,(06):374.[doi:10.16151/j.1007-810x.2018.11.012]
[2]陈 军,汪志明.第五届钟山国际外科感染论坛会议纪要[J].肠外与肠内营养杂志,2019,(01):26.[doi:10.16151/j.1007-810x.2019.01.012]
[3]陈文秀,孙加奎,沈 骁,等.早期肠内营养对脓毒症病人Th17/Treg细胞比及IL-23/IL-17轴的调节与临床意义[J].肠外与肠内营养杂志,2019,(01):30.[doi:10.16151/j.1007-810x.2019.01.013]
 HEN Wen-xiu,SUN Jia-kui,SHEN Xiao,et al.The effects of early enteral nutrition on Th17/Treg ratio and IL-23/IL-17 axis in patients with sepsis and the clinical significance[J].PARENTERAL & ENTERAL NUTRITION,2019,(06):30.[doi:10.16151/j.1007-810x.2019.01.013]
[4]邸 洁,尚昱君,王素梅,等.基于喂养流程的脓毒症病人早期肠内营养耐受性的评估与管理[J].肠外与肠内营养杂志,2020,(01):50.[doi:DOI : 10.16151/j.1007-810x.2020.01.012]
 DI Jie,SHANG Yu-jun,WANG Su-mei,et al.Evaluation and management of early enteral nutrition tolerance in patients with sepsis based on feeding procedures[J].PARENTERAL & ENTERAL NUTRITION,2020,(06):50.[doi:DOI : 10.16151/j.1007-810x.2020.01.012]
[5]李百强,袁晨晨,董 杰,等.柚皮素对脂多糖诱导的脓毒症小鼠肠粘膜损伤保护作用研究[J].肠外与肠内营养杂志,2020,(03):181.[doi:DOI : 10.16151/j.1007-810x.2020.03.012]
 LI Bai-qiang,YUAN Chen-chen,DONG Jie,et al.Protective effect of naringenin on intestinal mucosal injury in mice with lipopolysaccharide-induced sepsis[J].PARENTERAL & ENTERAL NUTRITION,2020,(06):181.[doi:DOI : 10.16151/j.1007-810x.2020.03.012]
[6]王 玉,杨中文,高 丽,等.补充维生素D对脓毒症儿童炎症反应的调节及其临床干预作用的应用[J].肠外与肠内营养杂志,2020,(04):215.[doi:10.16151/j.1007-810x.2020.04.006]
 WANG Yu,YANG Zhong-wen,GAO Li,et al.The effects of vitamin D supplementation on the regulation of inflammation and clinical outcomes in children with sepsis[J].PARENTERAL & ENTERAL NUTRITION,2020,(06):215.[doi:10.16151/j.1007-810x.2020.04.006]
[7]曹 春,何凯明,陈 伟,等.富辛酸肠内营养通过抑制JNK诱导的肝细胞凋亡缓解脓毒症急 性肝损伤[J].肠外与肠内营养杂志,2021,(05):262.[doi:10.16151/j.1007-810x.2021.05.002]
 CAO Chun,HE Kai-ming,CHEN Wei,et al.Octanoic acid-rich enteral nutrition could alleviate sepsis-induced acute liver injury through inhibition of JNK-mediated hepatocyte apoptosis[J].PARENTERAL & ENTERAL NUTRITION,2021,(06):262.[doi:10.16151/j.1007-810x.2021.05.002]
[8]李 晗,田李均,徐俊贤,等.早期肠内营养治疗对脓毒症及脓毒性休克治疗效果的Meta分析[J].肠外与肠内营养杂志,2022,(01):35.[doi:DOI : 10.16151/j.1007-810x.2022.01.007]
 LI Han,TIAN Li-jun,XU Jun-xian,et al.A Meta-analysis of the effect for early enteral nutrition support in sepsis and septic shock[J].PARENTERAL & ENTERAL NUTRITION,2022,(06):35.[doi:DOI : 10.16151/j.1007-810x.2022.01.007]
[9]唐玉秀,韦 瑶,金 钧.肠-肺轴以及粪菌移植在脓毒症中的作用[J].肠外与肠内营养杂志,2023,(03):179.[doi:10.16151/j.1007-810x.2023.03.010]
 TANG Yu-xiu,WEI Yao,JIN Jun.Function of gut-lung axis and fecal bacteria transplantation in sepsis[J].PARENTERAL & ENTERAL NUTRITION,2023,(06):179.[doi:10.16151/j.1007-810x.2023.03.010]

备注/Memo

备注/Memo:
基金项目 :安徽省教育厅科学研究项目(伦科批字[2022]第 191号)作者简介 :黄利民,主治医师,医学硕士,从事急诊医学工作。E-mail:18351875182@163.com通讯作者 :陆国玉,E-mail:1359112431@qq.com
更新日期/Last Update: 1900-01-01